...PIK3CA, PTEN, and AKT, which lead to excessive and constitutive activation of Akt and downstream signaling that results ...
...PIK3CA mutations were 38.6% (51/132), 3.6% (5/132), 5.1% (7/132), 5.1% (7/132), and 8.7% (12/132), respectively. With a ...
...PIK3CA and MET in 16% more patients than previously published variant calls. We believe VarDict will greatly facilitate ...
...PIK3CA, ALK, ERBB2, DDR2, MAP2K1, RET, and EGFR gene mutational analysis was also performed in all tumors.
...PIK3CA mutation status, expression of cyclo-oxygenase-2 and human leukocyte antigen class I, along with certain germline...
...PIK3CA in tumor stages. Combinations of one to three driver genes specifically dominated in each cancer. Across the clin...
...PIK3CA-mutant (HER2+/PIK3CAmut) status in breast tumor cell lines. In HER2+/PIK3CAmut cells, mTORC2 controls Ser-455 pho...
...PIK3CA (n=5; one also had a KRAS mutation), and HRAS (n=1) mutations.,Cidofovir at a dose of 5mg/kg combined with chemor...
...PIK3CA mutation. PIK3CA mutations were more frequent in myxoid/round cell and pleomorphic tumors compared with well-diff...
...PIK3CA in distal EBD carcinoma and evaluate the association with clinicopathological factors. Ninety cases of distal ext...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
